0001209191-18-040121.txt : 20180629
0001209191-18-040121.hdr.sgml : 20180629
20180629193211
ACCESSION NUMBER: 0001209191-18-040121
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180628
FILED AS OF DATE: 20180629
DATE AS OF CHANGE: 20180629
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: GORMAN KEVIN CHARLES
CENTRAL INDEX KEY: 0001201096
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-22705
FILM NUMBER: 18930553
MAIL ADDRESS:
STREET 1: 12790 EL CAMINO REAL
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: NEUROCRINE BIOSCIENCES INC
CENTRAL INDEX KEY: 0000914475
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 330525145
STATE OF INCORPORATION: CA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 12780 EL CAMINO REAL
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
BUSINESS PHONE: (858) 617-7600
MAIL ADDRESS:
STREET 1: 12780 EL CAMINO REAL
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2018-06-28
0
0000914475
NEUROCRINE BIOSCIENCES INC
NBIX
0001201096
GORMAN KEVIN CHARLES
12780 EL CAMINO REAL
SAN DIEGO
CA
92130
1
1
0
0
Chief Executive Officer
Common Stock
2018-06-28
4
M
0
23168
5.76
A
370201
D
Common Stock
2018-06-28
4
M
0
16551
8.66
A
386752
D
Common Stock
2018-06-28
4
M
0
10199
8.65
A
396951
D
Common Stock
2018-06-28
4
M
0
7142
19.59
A
404093
D
Common Stock
2018-06-28
4
M
0
864
32.99
A
404957
D
Incentive Stock Option
5.76
2018-06-28
4
M
0
23168
5.76
D
2011-09-25
2021-08-25
Common Stock
23168
0
D
Incentive Stock Option
8.66
2018-06-28
4
M
0
16551
8.66
D
2012-02-12
2022-01-12
Common Stock
16551
0
D
Incentive Stock Option
8.65
2018-06-28
4
M
0
10199
8.65
D
2013-02-10
2023-01-10
Common Stock
10199
0
D
Incentive Stock Option
19.59
2018-06-28
4
M
0
7142
19.59
D
2014-02-16
2024-01-16
Common Stock
7142
0
D
Incentive Stock Option
32.99
2018-06-28
4
M
0
864
32.99
D
2015-03-03
2025-02-03
Common Stock
864
3031
D
Represents option of which 1/36th of the shares underlying the option vested on September 25, 2011 and an additional 1/36th of the shares underlying the option vested each month thereafter.
Represents option of which 1/48th of the shares underlying the option vested on February 12, 2012 and an additional 1/48th of the shares underlying the option vested each month thereafter.
Represents option of which 1/48th of the shares underlying the option vested on February 10, 2013 and an additional 1/48th of the shares underlying the option vested each month thereafter.
Represents option of which 1/48th of the shares underlying the option vested on February 16, 2014 and an additional 1/48th of the shares underlying the option vested each month thereafter.
Represents option of which 1/48th of the shares underlying the option vested on March 3, 2015 and an additional 1/48th of the shares underlying the option vested each month thereafter.
/s/ Darin Lippoldt, Attorney-in-Fact
2018-06-29